Cargando…
A Clinical Framework for Assessing Cannabis-Related Impairment Risk
Clinicians play an important role in promoting safe and responsible medical cannabis use. One essential component to safe use is considering a patient's risk of neurocognitive impairment. However, there remains a lack of practical guidance on how clinicians can evaluate this risk for medical ca...
Autores principales: | MacCallum, Caroline A., Lo, Lindsay A., Pistawka, Carly A., Christiansen, April, Boivin, Michael, Snider-Adler, Melissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272752/ https://www.ncbi.nlm.nih.gov/pubmed/35832600 http://dx.doi.org/10.3389/fpsyt.2022.883517 |
Ejemplares similares
-
A Clinical Framework for Evaluating Cannabis Product Quality and Safety
por: MacCallum, Caroline A., et al.
Publicado: (2023) -
Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review
por: Eadie, Lauren, et al.
Publicado: (2021) -
Therapeutic use of psilocybin: Practical considerations for dosing and administration
por: MacCallum, Caroline A., et al.
Publicado: (2022) -
Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain
por: MacCallum, Caroline A., et al.
Publicado: (2021) -
Cannabis Use Disorder Impairs Motor Cortical Plasticity
por: Liu, Xiaoli, et al.
Publicado: (2020)